| References |
1. Mohamed ZH, El-Koussi NA, Mahfouz NM, Youssef AF, Abdel Jaleel GA, Shouman SA. Cu (I) catalyzed alkyne-azide 1,3-dipolar cycloaddition (CuAAC): Synthesis of 17α-[1-(substituted phenyl)-1,2,3-triazol-4-yl]-19-nor-testosterone-17β-yl acetates targeting progestational and antipro-liferative activities. Eur J Med Chem. 2015 Jun 5;97:75-82. doi: 10.1016/j.ejmech.2015.04.045. Epub 2015 Apr 28. PubMed PMID: 25942354. 2. Dallagi T, Top S, Masi S, Jaouen G, Saidi M. Synthesis and biodistribution of [99mTc]-N-[4-nitro-3-trifluoromethyl-phenyl] cyclopentadienyltricarbonyltechnetium carboxamide, a nonsteroidal antiandrogen flutamide derivative. Metallomics. 2010 Apr;2(4):289-93. doi: 10.1039/b925224j. Epub 2010 Feb 12. PubMed PMID: 21069171. 3. Murugkar A, Unnikrishnan B, Padhye S, Bhonde R, Teat S, Triantafillou E, Sinn E. Hormone anchored metal complexes. 1. Synthesis, structure, spectroscopy and in vitro antitumor activity of testosterone acetate thiosemicarbazone and its metal complexes. Met Based Drugs. 1999;6(3):177-82. doi: 10.1155/MBD.1999.177. PubMed PMID: 18472909; PubMed Central PMCID: PMC2366831. 4. Couture JF, de Jésus-Tran KP, Roy AM, Cantin L, Côté PL, Legrand P, Luu-The V, Labrie F, Breton R. Comparison of crystal structures of human type 3 3alpha-hydroxysteroid dehydrogenase reveals an "induced-fit" mechanism and a conserved basic motif involved in the binding of androgen. Protein Sci. 2005 Jun;14(6):1485-97. PubMed PMID: 15929998; PubMed Central PMCID: PMC2253370. |
